Tapimio 50 mg prolonged-release tablets
- Licence status
- Withdrawn: 21/11/2024
- Active substances
- Tapentadol phosphate
- Dosage Form
- Prolonged-release tablet
- Licence number
- PA23229/005/002
- Licence holder
- Neuraxpharm Ireland Limited
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- N02AX06 tapentadol
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 2017
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 04/11/2022